News
The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...
Just a week remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward restricting one of history's deadliest pandemics.
The World Health Organization has recommended the use of injectable lenacapavir (LEN) twice a year as an additional ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were ...
A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
17h
Health and Me on MSNWHO Recommends New HIV Twice-Yearly Shot Amid Fund Cuts; What Are The Big Challenges The Drug Faces?WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results